PA
COUR icon

PharVision Advisers’s Coursera COUR Stock Holding History

PharVision Advisers’s Portfolio COUR Stock Details COUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.9K Buy
+14,528
New +$82.5K 1.54% 31
2026
Q1 		– Sell
-33,353
Closed -$245K – 223
2025
Q4 		$245K Buy
33,353
+10,135
+44% +$88.3K 0.12% 403
2025
Q3 		$272K Buy
+23,218
New +$252K 0.15% 287
2025
Q2 		– Sell
-12,983
Closed -$86.5K – 297
2025
Q1 		$86.5K Buy
+12,983
New +$103K 0.12% 254

Other funds holding COUR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $2.93B AUM 37.21% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IHG
Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return
WCM
Westerly Capital Management San Francisco, California $542M AUM 48.48% 1-Year Est. Return

PharVision Advisers's COUR Position: Q2 2026 in Review

PharVision Advisers opened a new position in Coursera (COUR) in Q2 2026: 14,528 shares worth $81.9K. The stake represents 1.54% of the portfolio and ranks #31 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in COUR as recently as Q4 2025.

PharVision Advisers first reported a position in COUR in Q1 2025 and has held it in 4 quarters since. The position peaked at $272K in Q3 2025. 249 funds tracked by Wall St. Rank hold COUR as of Q2 2026.

  • PharVision Advisers held 14,528 shares of Coursera worth $81.9K as of Q2 2026.
  • Coursera was a new PharVision Advisers position in Q2 2026.
  • Coursera made up 1.54% of PharVision Advisers's portfolio in Q2 2026, its #31 holding.
  • PharVision Advisers first reported a position in Coursera in Q1 2025 and has held it in 4 quarters since.
  • PharVision Advisers's Coursera position peaked at $272K in Q3 2025.
  • 249 funds tracked by Wall St. Rank held Coursera as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.